Immunocore IMCR
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–
IMCR Stock News
Headlines matching Immunocore or the IMCR ticker, most recent first.
- H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
- Needham Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $75
- Morgan Stanley Maintains Immunocore(IMCR.US) With Hold Rating, Raises Target Price to $43 Positive
- Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $74 Positive
- J.P. Morgan Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $50
- Immunocore Holdings (IMCR) Gets a Buy From H.C. Wainwright
- Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Cuts Target Price to $34 Negative
- TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
- Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $73 Positive
- Oppenheimer Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $86
- Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $38
- Wells Fargo Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $60
- Jefferies Initiates Immunocore(IMCR.US) With Hold Rating, Announces Target Price $33
- Mizuho Securities Maintains Immunocore(IMCR.US) With Hold Rating, Maintains Target Price $37
- Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $72 Negative
No comments yet — be the first to weigh in on IMCR.
Sign in to join the discussion.